Overview
- 47 inspections across 42 sites are on record.
- 79 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2015-05-08.
At a glance
Inspections
47
Sites
42
Observations
79
Career since
Jan 2008
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Impax Laboratories, Inc. | 8 May 2015 | Human Drugs | View 483 → |
| Otsuka Pharmaceutical Co., Ltd. | 5 Dec 2014 | Human Drugs | On file |
| Allergan Sales, LLC | 6 Sep 2013 | Human Drugs | On file |
| Biomarin Pharmaceutical Inc. | 28 Jun 2013 | Human Drugs | |
| BioZone Laboratories Inc. | 20 Jun 2013 | Human Drugs |
Sites inspected
Impax Laboratories, Inc.Hayward, United States1 insp.
Otsuka Pharmaceutical Co., Ltd.Kanzaki-Gun, Japan1 insp.
Allergan Sales, LLCCampbell, United States1 insp.
Biomarin Pharmaceutical Inc.Novato, United States1 insp.
BioZone Laboratories Inc.Pittsburg, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Dongping Dai4 shared
Walden H Lee3 shared
Ivis L Negron Torres3 shared
Ashar P Parikh2 shared
Stephanie A Slater2 shared
Jennifer L Johnson2 shared
Thomas S Savage2 shared
Parul M Patel2 shared
Michael E Maselli2 shared
Rebecca Rodriguez1 shared
Full investigator report
Get the verbatim findings behind Uduak M Inokon's 79 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site